FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Chambers

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Janet B Henrich; Joseph T Chambers; Jeanne L Steiner
Development of an interdisciplinary women's health training model.
Lubna Pal; Vinita Parkash; Joseph T Chambers
Eosinophilia and uterine leiomyosarcoma.
Joseph T Chambers; Thomas Rutherford; Peter E Schwartz; Maria Luisa Carcangiu; Setsuko K Chambers; L Baker
A pilot study of topotecan in the treatment of serous carcinoma of the uterus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Chambers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Janet B Henrich; Joseph T Chambers; Jeanne L Steiner
Development of an interdisciplinary women's health training model.
Academic medicine : journal of the Association of American Medical Colleges 2003;78(9):877-84.
2003: Lubna Pal; Vinita Parkash; Joseph T Chambers
Eosinophilia and uterine leiomyosarcoma.
Obstetrics and gynecology 2003;101(5 Pt 2):1130-2.
2003: Joseph T Chambers; Thomas Rutherford; Peter E Schwartz; Maria Luisa Carcangiu; Setsuko K Chambers; L Baker
A pilot study of topotecan in the treatment of serous carcinoma of the uterus.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(2):216-22.
2003: Omer T Yalcin; Thomas Rutherford; Setsuko K Chambers; Joseph T Chambers; Peter E Schwartz
Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failure.
European journal of obstetrics, gynecology, and reproductive biology 2003;106(1):64-8.
2002: Bernadette Cracchiolo; Hartmut M Hanauske-Abel; Peter E Schwartz; Joseph T Chambers; Bart Holland; Setsuko K Chambers
Procollagen-derived biomarkers in malignant ascites of ovarian cancer. Independent prognosticators for progression-free interval and survival.
Gynecologic oncology 2002;87(1):24-33.
2001: E P Toy; Joseph T Chambers; Barry M Kacinski; Maryann B Flick; Setsuko K Chambers
The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma.
Gynecologic oncology 2001;80(2):194-200.
1999: Masoud Azodi; Setsuko K Chambers; Thomas Rutherford; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
Adenocarcinoma in situ of the cervix: management and outcome.
Gynecologic oncology 1999;73(3):348-53.
1999: Peter E Schwartz; Thomas Rutherford; Joseph T Chambers; Ernest I Kohorn; R P Thiel
Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival.
Gynecologic oncology 1999;72(1):93-9.
1998: Kunle Odunsi; L L Peck; Ernest I Kohorn; Vinita Parkash; Bernadette Cracchiolo; Joseph T Chambers; Kenneth J W Taylor
Necrosis of myometrial choriocarcinoma with fulminating sepsis complicating chemotherapy for trophoblastic tumor.
Gynecologic oncology 1998;70(1):100-4.
1998: FV Price; Setsuko K Chambers; Maria Luisa Carcangiu; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
CA 125 may not reflect disease status in patients with uterine serous carcinoma.
Cancer 1998;82(9):1720-5.
1997: Maria Luisa Carcangiu; L K Tan; Joseph T Chambers
Stage IA uterine serous carcinoma: a study of 13 cases.
The American journal of surgical pathology 1997;21(12):1507-14.
1997: Setsuko K Chambers; Joseph T Chambers; C A Davis; Ernest I Kohorn; Peter E Schwartz; M I Lorber; Robert E Handschumacher; Giuseppe Pizzorno
Pharmacokinetic and phase I trial of intraperitoneal carboplatin and cyclosporine in refractory ovarian cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1945-52.
1997: Frederick Naftolin; Thomas Rutherford; Joseph T Chambers; Maria Luisa Carcangiu
Wanted: more evidence on whether estrogen replacement causes cancer.
Journal of the Society for Gynecologic Investigation 1997;4(2):57.
1996: Setsuko K Chambers; C A Davis; Joseph T Chambers; Peter E Schwartz; M I Lorber; R E Hschumacher
Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(10):1699-704.
1996: Setsuko K Chambers; C A Davis; Peter E Schwartz; Ernest I Kohorn; Joseph T Chambers
Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(10):1693-7.
1996: I Cass; E Resnik; Joseph T Chambers; Setsuko K Chambers; Maria Luisa Carcangiu; Ernest I Kohorn; Peter E Schwartz
Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa.
Gynecologic oncology 1996;61(3):309-14.
1996: TG Zreik; Joseph T Chambers; Setsuko K Chambers
Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer.
Obstetrics and gynecology 1996;87(5 Pt 1):741-6.
1996: D A Fishman; K B Roberts; Joseph T Chambers; Ernest I Kohorn; Peter E Schwartz; Setsuko K Chambers
Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometrium.
Gynecologic oncology 1996;61(2):189-96.
1996: Joseph T Chambers; Setsuko K Chambers; Ernest I Kohorn; Maria Luisa Carcangiu; Peter E Schwartz
Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide.
Gynecologic oncology 1996;60(3):438-42.
1996: Laurence A Cole; A Tanaka; G S Kim; S Y Park; M W Koh; Peter E Schwartz; Joseph T Chambers; J H Nam
Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
Gynecologic oncology 1996;60(2):264-70.
1995: E Resnik; Setsuko K Chambers; Maria Luisa Carcangiu; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus.
Gynecologic oncology 1995;56(3):370-5.
1995: D A Fishman; Setsuko K Chambers; Peter E Schwartz; Ernest I Kohorn; Joseph T Chambers
Extramammary Paget's disease of the vulva.
Gynecologic oncology 1995;56(2):266-70.
1995: Leslie Scoutt; Shirley M McCarthy; Stuart D Flynn; Robert C Lange; F Long; Robert C Smith; Setsuko K Chambers; Ernest I Kohorn; P Schwartz; Joseph T Chambers
Clinical stage I endometrial carcinoma: pitfalls in preoperative assessment with MR imaging. Work in progress.
Radiology 1995;194(2):567-72.
1995: Maria Luisa Carcangiu; Joseph T Chambers
Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1995;14(1):30-8.
1994: M Rosman; C L Hayden; R P Thiel; Joseph T Chambers; Ernest I Kohorn; S K Chambers; Peter E Schwartz
Prognostic indicators for poor risk epithelial ovarian carcinoma.
Cancer 1994;74(4):1323-8.
1994: Setsuko K Chambers; L Lamb; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
Gynecologic oncology 1994;53(2):161-9.
1994: Peter E Schwartz; Joseph T Chambers; R Makuch
Neoadjuvant chemotherapy for advanced ovarian cancer.
Gynecologic oncology 1994;53(1):33-7.
1993: FV Price; Setsuko K Chambers; Maria Luisa Carcangiu; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC).
Gynecologic oncology 1993;51(3):383-9.
1993: FV Price; Setsuko K Chambers; Joseph T Chambers; Maria Luisa Carcangiu; Peter E Schwartz; Ernest I Kohorn; E Richard Stanley; Barry M Kacinski
Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.
American journal of obstetrics and gynecology 1993;168(2):520-7.
1992: Maria Luisa Carcangiu; Joseph T Chambers
Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
Gynecologic oncology 1992;47(3):298-305.
1992: B E Nelson; Maria Luisa Carcangiu; Joseph T Chambers
Intraabdominal hemorrhage with pulmonary large cell carcinoma metastatic to the ovary.
Gynecologic oncology 1992;47(3):377-81.
1992: P E Schwartz; Setsuko K Chambers; Joseph T Chambers; E Kohorn; S McIntosh
Ovarian germ cell malignancies: the Yale University experience.
Gynecologic oncology 1992;45(1):26-31.
1991: A H Frank; P C Tseng; Bruce G Haffty; D P Papadopoulos; Barry M Kacinski; S W Dowling; Maria Luisa Carcangiu; Ernest I Kohorn; Joseph T Chambers; Setsuko K Chambers
Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma.
Cancer 1991;68(7):1516-9.
1991: Setsuko K Chambers; Joseph T Chambers; R Kier; Richard E Peschel
Sequelae of lateral ovarian transposition in irradiated cervical cancer patients.
International journal of radiation oncology, biology, physics 1991;20(6):1305-8.
1991: Joseph T Chambers
Outpatient surgery in gynecologic oncology.
Current opinion in obstetrics & gynecology 1991;3(3):379-84.
1990: J H Nam; Joseph T Chambers; Peter E Schwartz; Laurence A Cole
Urinary gonadotropin fragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors.
Gynecologic oncology 1990;39(3):352-7.
1990: Setsuko K Chambers; Joseph T Chambers; C Holm; Richard E Peschel; Peter E Schwartz
Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients.
Gynecologic oncology 1990;39(2):155-9.
1990: Joseph T Chambers; Maria Luisa Carcangiu; I M Voynick; Peter E Schwartz
Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival.
American journal of clinical pathology 1990;94(3):255-60.
1990: Maria Luisa Carcangiu; Joseph T Chambers; I M Voynick; M Pirro; Peter E Schwartz
Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlations.
American journal of clinical pathology 1990;94(3):247-54.
1990: J H Nam; K C Chang; Joseph T Chambers; Peter E Schwartz; Laurence A Cole
Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers.
Gynecologic oncology 1990;38(1):66-70.
1990: Joseph T Chambers; Setsuko K Chambers; I M Voynick; Peter E Schwartz
Neoadjuvant chemotherapy in stage X ovarian carcinoma.
Gynecologic oncology 1990;37(3):327-31.
1990: Laurence A Cole; J H Nam; Joseph T Chambers; Peter E Schwartz
Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass.
Gynecologic oncology 1990;36(3):391-4.
1990: J H Nam; Laurence A Cole; Joseph T Chambers; Peter E Schwartz
Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity.
Gynecologic oncology 1990;36(3):383-90.
1990: Joseph T Chambers; Setsuko K Chambers; Peter E Schwartz
Correlation between measured creatinine clearance and calculated creatinine clearance in ovarian cancer patients.
Gynecologic oncology 1990;36(1):66-8.
1989: Setsuko K Chambers; R L Chopyk; Joseph T Chambers; Peter E Schwartz; T P Duffy
Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer.
Cancer 1989;64(12):2459-61.
1989: P C Tseng; H E Sprance; Maria Luisa Carcangiu; Joseph T Chambers; Peter E Schwartz
CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
Obstetrics and gynecology 1989;74(3 Pt 1):384-7.
1989: Barry M Kacinski; E Richard Stanley; Darryl L Carter; Joseph T Chambers; Setsuko K Chambers; Ernest I Kohorn; Peter E Schwartz
Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms.
International journal of radiation oncology, biology, physics 1989;17(1):159-64.
1989: Peter E Schwartz; Joseph T Chambers; Ernest I Kohorn; Setsuko K Chambers; H Weitzman; I M Voynick; N MacLusky; Frederick Naftolin
Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial.
Cancer 1989;63(6):1074-8.
1989: C Kramer; Richard E Peschel; N Goldberg; Ernest I Kohorn; Joseph T Chambers; Setsuko K Chambers; Peter E Schwartz
Radiation treatment of FIGO stage IVA carcinoma of the cervix.
Gynecologic oncology 1989;32(3):323-6.
1989: Peter E Schwartz; Setsuko K Chambers; Joseph T Chambers; K Tilton; R Foemmel
CA 125 in peritoneal washings and fluid: correlation with plasma CA 125 and peritoneal cytology.
Obstetrics and gynecology 1989;73(3 Pt 1):339-42.
1989: Setsuko K Chambers; Stuart D Flynn; S A Del Prete; Joseph T Chambers; Peter E Schwartz
Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.
Gynecologic oncology 1989;32(3):303-9.
1988: Joseph T Chambers; M J Merino; Ernest I Kohorn; Peter E Schwartz
Borderline ovarian tumors.
American journal of obstetrics and gynecology 1988;159(5):1088-94.
1988: Barry M Kacinski; Darryl L Carter; K Mittal; Ernest I Kohorn; R S Bloodgood; J Donahue; L Donofrio; R Edwards; Peter E Schwartz; Joseph T Chambers
High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas.
International journal of radiation oncology, biology, physics 1988;15(4):823-9.
1988: Y X Wang; Peter E Schwartz; Joseph T Chambers; Laurence A Cole
Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies.
Gynecologic oncology 1988;31(1):91-102.
1988: Joseph T Chambers; N MacLusky; A Eisenfield; Ernest I Kohorn; R Lawrence; Peter E Schwartz
Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer.
Gynecologic oncology 1988;31(1):65-81.
1988: Setsuko K Chambers; Joseph T Chambers; E I Kohorn; R Lawrence; Peter E Schwartz
Evaluation of the role of second-look surgery in ovarian cancer.
Obstetrics and gynecology 1988;72(3 Pt 1):404-8.
1988: Laurence A Cole; Y X Wang; M Elliott; M Latif; Joseph T Chambers; Setsuko K Chambers; Peter E Schwartz
Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cancer research 1988;48(5):1356-60.
1987: Peter E Schwartz; Setsuko K Chambers; Joseph T Chambers; J Gutmann; N Katopodis; R Foemmel
Circulating tumor markers in the monitoring of gynecologic malignancies.
Cancer 1987;60(3):353-61.
1987: Joseph T Chambers; R Lawrence; N MacLusky; A Eisenfield; P E Schwartz
Circannual rhythms in steroid receptor concentration in gynecologic and breast cancers.
American journal of obstetrics and gynecology 1987;156(3):728-9.